Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Research & Development Expenses (Tables)

v3.22.1
Research & Development Expenses (Tables)
12 Months Ended
Dec. 31, 2021
Analysis of income and expense [abstract]  
Disclosure of summary of research and development expenses
For the Year Ended December 31,
2021 2020* 2019
$’000 $’000 $’000
Employee benefits
42,877  53,332  36,630 
Contractors and consultants expense
3,917  645  14,752 
Other
740  734  (177)
Total
47,534  54,711  51,205 
* Restated to reflect reclassification of certain expense items described in Note 2.